Insulin pumps
Topic Status Complete
Continuous subcutaneous insulin infusion (CSII or ‘insulin pumps’) for people with type 1 and gestational diabetes.
Summary
Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of continuous subcutaneous insulin infusion (CSII or ‘insulin pumps’) for people with type 1 and gestational diabetes. HTW’s Assessment Group reviewed this topic as part of a prioritisation exercise in February 2020 and concluded not to progress this topic further. This topic may be revisited in future and its suitability for fuller assessment reconsidered.
Topic Exploration Report
TER127 03.2020
